For risk takers; 5 midcap stocks from different sectors with right levels of RoE and upside potential of up to 32%Last week, mid-cap stocks saw a sharp correction, because there was no major follow up selling, making the overall trend stay in the bullis...
17 Sep, 2023, 12.42 PM IST
Tactical buys in time of correction? 4 MNC pharma stocks with upside potential of up to 28%In the last two decades MNC pharma companies, whose parent companies were setting up 100 percent owned subsidiaries in India and started ro...
12 Sep, 2023, 02.36 PM IST
Will they make a comeback? 4 MNC pharma stocks with upside potential of up to 28%After the IT bull of 2000, as a new set of Indian companies took the centerstage, a number of MNCs stocks lost their shine at least on the ...
09 Sep, 2023, 02.44 PM IST
Will MNC pharma stocks get back their mojo for good or is it just a blip?Most of the MNC pharma companies have formed their subsidiary and a large majority of new drugs launched in India were via this route. This...
23 May, 2023, 02.10 PM IST
High ROE & net profit margin, 4 stocks with two key elements of long term wealth creatorsThere are some businesses which require a constant dose of capital and banking is one of them. There are some which may require a higher am...
08 Jan, 2023, 12.24 PM IST
Biological E's Pneumonia jab for kids gets nodStreptococcus pneumoniae infection is a leading cause of child mortality under 5 years of age in India and other developing countries.
02 Sep, 2022, 12.14 AM IST
BE's pediatric pneumonia jab gets CDSCO expert panel approvalThe BE's pneumococcal conjugate vaccine (PCV) can be administered to infants at 6, 10 and 14 weeks of age. Streptococcus pneumoniae infecti...
01 Sep, 2022, 05.46 PM IST
Buy Pfizer, target price Rs 6500: Centrum BrokingPfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 25522.43 Crore) operating in Pharmaceuticals ...
29 Jun, 2021, 09.34 AM IST
Hold Pfizer, target price Rs 4,665: Anand RathiThe pharma major launched its patented product, Zavicefta, in India in H1 FY20. This was the first anti-infective drug launched by Pfizer i...
27 Apr, 2020, 01.15 PM IST
Add Pfizer, target price Rs 3,400: Centrum BrokingManagement is hopeful of achieving in-line or slightly better growth rate than the market.
09 Sep, 2019, 12.28 PM IST
MSF drags govt to Delhi HC over Pfizer's pneumonia vaccine patentThe Indian patent office granted Pfizer a patent for its vaccine PCV13 (13-valent pneumococcal conjugate vaccine), sold here under the bran...
14 Oct, 2017, 02.08 AM IST
India grants Pfizer patent for blockbuster brand Prevenar 13India has seven pneumonia related deaths per 1,000 live births, according to the 2016 Pneumonia and Diarrhea Progress Report.
23 Aug, 2017, 08.33 AM IST
Pfizer plans to bring more global drugs to IndiaAlthough the company sells most of its top 20 global products in India, it is looking to bring in a couple of drugs, the patents of which h...
15 Aug, 2016, 11.09 AM IST
MSF and Pfizer battle over patent application for life-saving pneumonia vaccineMSF filed declarations at the Delhi patent office to point out that Pfizer's 13-valent pneumococcal conjugate vaccine (PCV13) was obvious a...
29 Jul, 2016, 11.05 PM IST
Pfizer may leverage European approval to pneumonia vaccine in Indian marketNew York-headquartered pharmaceutical giant is likely to leverage its latest European approval for multi-dose vials of pneumococcal vaccine...
07 Apr, 2016, 01.01 AM IST
Doctors Without Borders challenges Pfizer's vaccine patent application in IndiaNot-for-profit medical charity Doctors Without Borders (MSF) has challenged a patent application of US drug major Pfizer in India for its p...
12 Mar, 2016, 06.17 PM IST
- Action against Wyeth for death of infant: DGCI
The Drug Controller General of India (DCGI) has said that action will be taken against the guilty for the death of an infant during a clini...
19 Jan, 2009, 07.28 PM IST